These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 3781466)
1. [Mechanisms of development of resistance to methotrexate in choriocarcinoma cells]. Sakai K Hokkaido Igaku Zasshi; 1986 Sep; 61(5):649-61. PubMed ID: 3781466 [TBL] [Abstract][Full Text] [Related]
2. [MTX resistant mechanisms in human choriocarcinoma cells]. Sakai K; Fujino T; Hoshi S; Shinkai N; Hashimoto M; Yasuda T; Kato H; Yamada H; Wake N; Ichinoe K Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):807-14. PubMed ID: 3474305 [TBL] [Abstract][Full Text] [Related]
3. Methotrexate-resistant mechanisms in human choriocarcinoma cells. Sakai K; Wake N; Fujino T; Yasuda T; Kato H; Fujimoto S; Fujinaga K Gynecol Oncol; 1989 Jul; 34(1):7-11. PubMed ID: 2737530 [TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of resistance to antifolates, a review. Banerjee D; Ercikan-Abali E; Waltham M; Schnieders B; Hochhauser D; Li WW; Fan J; Gorlick R; Goker E; Bertino JR Acta Biochim Pol; 1995; 42(4):457-64. PubMed ID: 8852336 [TBL] [Abstract][Full Text] [Related]
5. Phenotypic heterogeneity in cultured human head and neck squamous cell carcinoma lines with low-level methotrexate resistance. Rosowsky A; Wright JE; Cucchi CA; Lippke JA; Tantravahi R; Ervin TJ; Frei E Cancer Res; 1985 Dec; 45(12 Pt 1):6205-12. PubMed ID: 2415240 [TBL] [Abstract][Full Text] [Related]
6. Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate. Diddens H; Niethammer D; Jackson RC Cancer Res; 1983 Nov; 43(11):5286-92. PubMed ID: 6225514 [TBL] [Abstract][Full Text] [Related]
7. Potentiation of carcinogen-induced methotrexate resistance and dihydrofolate reductase gene amplification by inhibitors of poly(adenosine diphosphate-ribose) polymerase. Bürkle A; Heilbronn R; zur Hausen H Cancer Res; 1990 Sep; 50(18):5756-60. PubMed ID: 2118419 [TBL] [Abstract][Full Text] [Related]
9. [Localization of dihydrofolate reductase amplified genes in Chinese hamster cells resistant to methotrexate]. Mukhamedkhanova FS; Kuznetsova NN; Nuridzhaniants SS; Abdurkarimov AA Genetika; 1987 Sep; 23(9):1588-94. PubMed ID: 3692154 [TBL] [Abstract][Full Text] [Related]
10. Selective expression of methotrexate-resistant dihydrofolate reductase (DHFR) activity in mice transduced with DHFR retrovirus and administered methotrexate. Vinh DB; McIvor RS J Pharmacol Exp Ther; 1993 Nov; 267(2):989-96. PubMed ID: 8246174 [TBL] [Abstract][Full Text] [Related]
11. Selection for methotrexate resistance in mammalian cells bearing a Drosophila dihydrofolate reductase transgene: Methotrexate resistance in transgenic mammalian cells. Affleck JG; Nowickyj SM; Walker VK Cell Biol Toxicol; 2010 Apr; 26(2):117-26. PubMed ID: 19337845 [TBL] [Abstract][Full Text] [Related]
12. Development of methotrexate-resistant human choriocarcinoma cells in culture. Sekiya S; Kaiho T; Takamizawa H Gynecol Oncol; 1985 May; 21(1):46-53. PubMed ID: 4039287 [TBL] [Abstract][Full Text] [Related]
13. Effect of methotrexate on dihydrofolate reductase activity in methotrexate-resistant human KB cells. Domin BA; Grill SP; Bastow KF; Cheng YC Mol Pharmacol; 1982 Mar; 21(2):478-82. PubMed ID: 7099148 [TBL] [Abstract][Full Text] [Related]
14. Collateral sensitivity to azidothymidine in methotrexate resistant human leukemia cells. Miyachi H; Jiao L; Sowers LC; Scanlon KJ In Vivo; 1992; 6(1):17-21. PubMed ID: 1385729 [TBL] [Abstract][Full Text] [Related]
15. Dihydrofolate reductase transcript level is not suitable for methotrexate-resistance prediction in choriocarcinoma cell line. Han B; Xiang Y; Wang Y; Wang Z; Zhang H; Huang S Int J Gynecol Cancer; 2010 Oct; 20(7):1259-63. PubMed ID: 21495249 [TBL] [Abstract][Full Text] [Related]
16. [Methotrexate and its drug resistance]. Nagura E Gan To Kagaku Ryoho; 1988 Oct; 15(10):2882-7. PubMed ID: 3178237 [TBL] [Abstract][Full Text] [Related]
17. Dihydrofolate reductase binding and cellular uptake of nonpolyglutamatable antifolates: correlates of cytotoxicity toward methotrexate-sensitive and -resistant human head and neck squamous carcinoma cells. Chen G; Wright JE; Rosowsky A Mol Pharmacol; 1995 Oct; 48(4):758-65. PubMed ID: 7476904 [TBL] [Abstract][Full Text] [Related]
18. Transgenic mice expressing the tyr22 variant of murine DHFR: protection of transgenic marrow transplant recipients from lethal doses of methotrexate. James RI; May C; Vagt MD; Studebaker R; McIvor RS Exp Hematol; 1997 Nov; 25(12):1286-95. PubMed ID: 9357973 [TBL] [Abstract][Full Text] [Related]
19. Collateral methotrexate resistance in cultured human head and neck carcinoma cells selected for resistance to cis-diamminedichloroplatinum(II). Rosowsky A; Wright JE; Cucchi CA; Flatow JL; Trites DH; Teicher BA; Frei E Cancer Res; 1987 Nov; 47(22):5913-8. PubMed ID: 3664492 [TBL] [Abstract][Full Text] [Related]
20. Evolution of methotrexate resistance of human acute lymphoblastic leukemia cells in vitro. Ohnuma T; Lo RJ; Scanlon KJ; Kamen BA; Ohnoshi T; Wolman SR; Holland JF Cancer Res; 1985 Apr; 45(4):1815-22. PubMed ID: 3856477 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]